Organon Co Equity-NMS: OGN


Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$17.86
Open :$17.88
Today's high :$18.02
Today's low :$17.38
52W low :$10.84
52W high :$24.79
EPS(TTM): :3.99
Shares O/S :255.64 M
Market cap :4.56 B

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Organon Co today?

Organon Co (OGN) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Organon Co?

Yes, Indian Investors can invest in the Organon Co (OGN) Share by opening an international trading account with Angel One.

How can I purchase Organon Co shares in India?

Purchasing Organon Co (OGN) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Organon Co (OGN) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Organon Co?

Yes, you can purchase fractional shares of Organon Co (OGN) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Organon Co?

The market capitalization of Organon Co on January 1, 1970, is $0.

What documents are required to invest in Organon Co stocks?

In order to invest in Organon Co (OGN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Organon Co

Organon & Co. is a global health care company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and established brands. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. The Company’s Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, respiratory, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. The Company operates six manufacturing facilities, which are located in Belgium, Brazil, Indonesia, Mexico, the Netherlands and the United Kingdom.